Literature DB >> 9266431

Familial amyotrophic lateral sclerosis.

T Siddique1, D Nijhawan, A Hentati.   

Abstract

Amyotrophic lateral sclerosis is sporadic in ninety percent of cases and familial (FALS) in ten percent. Both forms of FALS whether transmitted as an autosomal dominant (DFALS) or as an autosomal recessive (RFALS) trait is genetically heterogeneous. The locus for one form of RFALS maps to chromosome 2q33. Fifteen percent of DFALS families have mutations in the gene for Cu, Zn superoxide dismutase (SOD1) gene which is coded on chromosome 21. These mutations result in decreased SOD1 activity and shortened half-life of the protein in most instances. Transgenic mice overexpressing mutated SOD1 protein develop an ALS-like disease which suggests that the degeneration of motor neurons in DFALS is caused by the gain of a novel toxic function by mutated SOD1 rather than by the decrease of SOD1 activity. Possible mechanisms of the novel neurotoxic function of mutated SOD1 are discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9266431     DOI: 10.1007/978-3-7091-6844-8_23

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  3 in total

Review 1.  Need for a paradigm shift in therapeutic approaches to CNS injury.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2012-04       Impact factor: 4.618

2.  Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening.

Authors:  Weiwei He; Hui-Min Zhang; Yeeting E Chong; Min Guo; Alan G Marshall; Xiang-Lei Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

3.  Vitamin E intake and risk of amyotrophic lateral sclerosis: a pooled analysis of data from 5 prospective cohort studies.

Authors:  Hao Wang; Éilis J O'Reilly; Marc G Weisskopf; Giancarlo Logroscino; Marjorie L McCullough; Arthur Schatzkin; Laurence N Kolonel; Alberto Ascherio
Journal:  Am J Epidemiol       Date:  2011-02-18       Impact factor: 4.897

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.